-
March 3, 2015PREVIEW
The risk of ovarian cancer may be increased in women who are current or previous users of hormone replacement therapy (HRT), according to results of a large meta-analysis published online in the...
-
January 27, 2015PREVIEW
Results of a recent study showed that pembrolizumab (Keytruda—Merck) may be an effective treatment for patients with certain types of advanced melanoma whose treatment failed with use of...
-
September 16, 2014PREVIEW
The oral agent ibrutinib (Imbruvica—Pharmacyclics, Janssen Biotech) was associated with improved progression-free survival, overall survival, and response rates compared with ofatumumab (Arzerra...
-
May 27, 2014PREVIEW
Treatment of relapsed/refractory mantle cell lymphoma (MCL) with ibrutinib (Imbruvica—Pharmacyclics) was associated with a response rate of 68%; prior treatment with bortezomib (Velcade—...
-
April 7, 2014PREVIEW
A 25-year follow-up study including nearly 90,000 Canadian women concluded that annual mammography screening in women aged 40 to 59 years did not reduce breast cancer mortality compared with...
Pages
